Fredrick Chite Asirwa

Prof. Fredrick Chite Asirwa M.D. is the CEO of International Cancer Institute, an organization whose main purpose is to expand Education, Clinical Care and Training opportunities in cancer control and research across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs. He is a Medical Oncologist & Hematologist, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program, Shining Tower Program, Clinical Trials Program-all geared towards enhancing early detection, promoting primary HPV screening, providing SOC diagnostics, therapeutics cancer research. He has developed several training programs including SSA Oncology Preceptorship training, Digital Pathology Program, Telemedicine Program, Oncology training for Physician assistants (Clinical Officers), development of Oncology Nursing training program in Kenya, Medical Oncology Fellowship Program and assisted in the development of gynecologic oncology program. He also conducts Clinical Trials in SSA. He was previously (2011-2019), the Director of AMPATH Oncology & Hematology Consortium in Kenya. In this role he developed infrastructure for telemedicine at AMPATH, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program, Lymphoma Program, functional tumor registry, Breast Cancer screening & treatment program, Hemophilia & Sickle cell Dx, Rx & research, EMR for Oncology care and screening, a multinational Lung Cancer Control Program (KE, RSA, Lesotho, TZ, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) of various Oncology Clinical Trial Centers. He has also been an active ASCO member through ASCO’s Multidisciplinary Cancer Management Course (MCMC), International Affairs Committee (IAC), Education Council, ASCO‘s Academic Global Oncology Task Force and as a Peer reviewer to ASCO Journals. He is also currently a member of ASCO-ESMO Global Oncology Curriculum committee. He did his Undergraduate training in Kenya and Post-graduate (Internal Medicine residency & Heme/Onc Fellowship) in the United States.